ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- Capital expenditures, FY2025
- $8.2M
- YoY, FY2025
- +78.5%
- 5-year CAGR
- +7.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| FY2025 | $8.2M | +78.5% |
| FY2024 | $4.6M | +232.8% |
| FY2023 | $1.4M | −89.1% |
| FY2022 | $13M | −27.2% |
| FY2021 | $17M | +200.3% |
| FY2020 | $5.8M | — |